Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research Regarding the Availability and Safety of UC-MSCs Treatment for Serious Pneumonia and Critical Pneumonia Caused by the 2019-nCOV Infection

NCT04269525 is registered in ClinicalTrials.gov with ZhiYong Peng as lead sponsor.

NCT NCT04269525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04269525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research Regarding the Availability and Safety of UC-MSCs Treatment for Serious Pneumonia and Critical Pneumonia Caused by the 2019-nCOV Infection
Lead sponsor
ZhiYong Peng
Phase
Phase 2
Overall status
Unknown status
Start date
February 6, 2020
Completion date
December 30, 2020
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia, ventilator-associated, pneumonia, viral